Sjögren's disease: open trials in France

20 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07917442
Evaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in Patients With Primary Sjögren's Syndrome
Trial Treatment · Centre Hospitalier Universitaire, Amiens
CHU Amiens, Amiens
Registry updated 2026-11-04
NCT07737743
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Centre Hospitalier Régional et Universitaire de Brest, Brest · Centre Hospitalier Universitaire de Caen Normandie, Caen · Centre Hospitalier Le Mans, Le Mans Cedex 9 · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-10-28
NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Trial Treatment · Phase 3 · Vor Biopharma
Centre Hospitalier Universitaire D'Angers, Angers · Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Centre Hospitalier Universitaire de Caen Normandie, Caen · Centre Hospitalier De Colmar, Colmar Cedex · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Hopitaux Universitaires Pitie Salpetriere, Paris Cedex 13 · Centre Hospitalier Universitaire De Saint Etienne, St Etienne Cedex 2 · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-10-19
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Montpellier · Paris
Registry updated 2026-10-14
NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Centre Hospitalier Universitaire D'Angers, Angers · Centre Hospitalier Blois Simone Veil, Blois Cedex · Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Centre Hospitalier Universitaire de Caen Normandie, Caen · Centre Hospitalier Universitaire de Dijon, Dijon · Centre Hospitalier Departemental Vendee, La Roche Sur Yon Cedex 9 · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Centre Hospitalier Le Mans, Le Mans Cedex 9 · Centre Hospitalier Universitaire de Lille, Lille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Assistance Publique Hopitaux De Paris, Paris Cedex 13 · Centre Hospitalier Universitaire de Saint Etienne, Saint-Etienne · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · HIA Sainte Anne, Toulon Cedex 9 · Centre Hospitalier de Valenciennes, Valenciennes · CHRU De Nancy, Vandoeuvre Les Nancy
Registry updated 2026-10-13
NCT07861828
Exploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's Syndrome
Trial Treatment · Centre Hospitalier Universitaire Dijon
Chu Dijon Bourgogne, Dijon
Registry updated 2026-10-06
NCT06875102
Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies
Trial Treatment · Centre Hospitalier Universitaire de Saint Etienne
Chu de Saint Etienne, Saint-Etienne
Registry updated 2026-09-30
NCT07760818
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
Trial Treatment · Phase 2 · argenx
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 10 · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-08-12
NCT07041099
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.
Chu Brest, Brest · Hôpitaux Universitaires Paris Sud, Le Kremlin-Bicêtre · CHU Nantes, Nantes · CHU St-Etienne, Saint Priest En Jarez · CHU Strasbourg-Hautepierre, Strasbourg
Registry updated 2026-08-11
NCT06977724
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · AbbVie
Centre Hospitalier Universitaire de Montpellier, Montpellier · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-08-10
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Centre Hospitalier Regional De Marseille, Marseille · Hospital Saint Eloi, Montpellier · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-07-31
NCT04931160
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
Trial Treatment · University Hospital, Brest
CHRU de Brest, Brest
Registry updated 2026-06-26
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-06-23
2025-521462-96-00
A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease
Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.
Centre Hospitalier Régional et Universitaire de Brest, Brest · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-05-06
NCT03003572
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Research · Centre Hospitalier Universitaire de Saint Etienne
CH Pierre Oudot, Bourgoin · CHU Estaing Clermont - Ferrand, Clermont-Ferrand · CHU Grenoble Alpes, Grenoble · Hôpital de la Croix Rousse, Lyon · CH Lyon Sud, Lyon · Hopital Edouard Herriot - CHU Lyon, Lyon · CHU Reims, Reims · CHU Saint-Etienne, Saint-Etienne
Registry updated 2026-05-06
NCT06747949
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Trial Treatment · Phase 3 · Amgen
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Bicetre Hospital, Le Kremlin Bicetre Cedex · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse · Assistance Publique Hopitaux de Paris, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-04-28
NCT06842316
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Research · Centre Hospitalier Régional d'Orléans
CHU d'Orléans, Orléans
Registry updated 2025-12-30
NCT05927688
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Research · University Hospital, Strasbourg, France
University Hospital of Strasbourg, Strasbourg
Registry updated 2025-03-12
NCT04848870
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
Research · Assistance Publique - Hôpitaux de Paris
Service de Médecine bucco-dentaire, Ivry-sur-Seine
Registry updated 2024-12-30
NCT06680310
Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
Research · University Hospital, Brest
Chu Brest, Brest
Registry updated 2024-11-08

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error